Total Liabilities (Quarterly) Chart

Historical Total Liabilities (Quarterly) Data

View and export this data back to 2007. Start Trial.
Date Value
June 30, 2026 93.91M
March 31, 2026 201.60M
December 31, 2025 202.83M
September 30, 2025 203.57M
June 30, 2025 203.60M
March 31, 2025 209.59M
December 31, 2024 204.03M
September 30, 2024 187.16M
June 30, 2024 182.95M
March 31, 2024 183.99M
December 31, 2023 196.62M
September 30, 2023 146.63M
June 30, 2023 140.12M
March 31, 2023 107.33M
December 31, 2022 105.79M
September 30, 2022 99.77M
June 30, 2022 99.40M
March 31, 2022 99.83M
December 31, 2021 94.59M
September 30, 2021 92.85M
June 30, 2021 89.28M
March 31, 2021 89.14M
December 31, 2020 99.78M
September 30, 2020 78.12M
June 30, 2020 74.16M
Date Value
March 31, 2020 75.64M
December 31, 2019 67.61M
September 30, 2019 65.35M
June 30, 2019 65.71M
March 31, 2019 69.97M
December 31, 2018 32.92M
September 30, 2018 51.59M
June 30, 2018 51.88M
March 31, 2018 52.66M
December 31, 2017 21.28M
September 30, 2017 46.47M
June 30, 2017 19.60M
March 31, 2017 14.55M
December 31, 2016 11.02M
September 30, 2016 11.04M
June 30, 2016 10.96M
March 31, 2016 11.02M
December 31, 2015
September 30, 2015 9.693M
June 30, 2015 10.03M
March 31, 2015 10.10M
December 31, 2014 8.138M
September 30, 2014 9.552M
June 30, 2014 6.812M
March 31, 2014 7.498M

Total Liabilities Definition

Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.

Read full definition.

Total Liabilities (Quarterly) Range, Past 5 Years

View Total Liabilities (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Liabilities (Quarterly) Benchmarks

View Total Liabilities (Quarterly) Benchmarks
Start Trial
3-D Matrix Ltd. 13.72M
Healios KK 88.08M
AnGes, Inc. 21.25M
ACADIA Pharmaceuticals, Inc. 436.29M
Alkermes Plc 2.585B

Total Liabilities (Quarterly) Related Metrics